Toronto, Canada | 8 April 2021 | ZEISS Vision Care
ZEISS Vision Care Canada, in collaboration with WestGroupe – the renowned eyewear manufacturer based in the United States and Canada – has pledged a donation of more than $110,000 to Optometry Giving Sight. Since 2016, both partners donated a portion of sales of each ValuePak eyewear frame and lens package to the global fundraising initiative. Founded in 2003, Optometry Giving Sight aims to prevent blindness and visual impairment caused by uncorrected vision loss and address the debilitating visual impairment problem. Globally, the organization funds various programs that provide much-needed vision care, train local eye care professionals and build sustainable infrastructure in developing countries.
Through joint support, ZEISS has helped fund critical local developments in countries such as an optometry school in Vietnam and the equipment for an optometry program in Malawi. Both countries will benefit from their newly trained optometrists by providing comprehensive eye exams where there was limited or no eye care.
ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling 6.3 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (status: 30 September 2020).
For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.
With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership. ZEISS invests 13 percent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future.
With over 32,000 employees, ZEISS is active globally in almost 50 countries with around 30 production sites, 60 sales and service companies and 27 research and development facilities. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.
Further information at www.zeiss.com
ZEISS Vision Care is one of the world's leading manufacturers of eyeglass lenses and ophthalmic instruments. The unit is allocated to the Consumer Markets segment and develops and produces offerings for the entire eyeglass value chain that are distributed globally under the ZEISS brand.